Pink Sheet Podcast: Califf Confirmed, Lessons From Sintilimab Adcom, Generic Industry Execs Meet
Pink Sheet reporters and editors consider Robert Califf’s priorities now that he is FDA commissioner, what sponsors can learn from the sintilimab advisory committee meeting, and the latest generics news from a major (and in-person) trade association conference.
You may also be interested in...
Pink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.
Pink Sheet reporter and editors discuss CDC advisors’ views on COVID-19 vaccine booster policy, new FDA guidance to promote clinical trial diversity, and what some FDA employees are finding when they return to the White Oak headquarters.